These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33876749)

  • 1. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
    Rivera OD; Mallory MJ; Quesnel-Vallières M; Chatrikhi R; Schultz DC; Carroll M; Barash Y; Cherry S; Lynch KW
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation.
    Hug N; Aitken S; Longman D; Raab M; Armes H; Mann AR; Rio-Machin A; Fitzgibbon J; Rouault-Pierre K; Cáceres JF
    RNA; 2022 Sep; 28(9):1224-1238. PubMed ID: 35768279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
    Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M
    Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
    Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
    Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients.
    Mechaal A; Menif S; Abbes S; Safra I
    Adv Med Sci; 2019 Sep; 64(2):395-401. PubMed ID: 31331874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
    Stomper J; Meier R; Ma T; Pfeifer D; Ihorst G; Blagitko-Dorfs N; Greve G; Zimmer D; Platzbecker U; Hagemeijer A; Schmitt-Graeff I; Lübbert M
    Clin Epigenetics; 2021 Apr; 13(1):77. PubMed ID: 33845873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
    Chu MQ; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Zhang W; Wen XM; Lin J; Qian J; Zhou JD
    J Cell Mol Med; 2020 Jan; 24(2):1640-1649. PubMed ID: 31794134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant splicing in B-cell acute lymphoblastic leukemia.
    Black KL; Naqvi AS; Asnani M; Hayer KE; Yang SY; Gillespie E; Bagashev A; Pillai V; Tasian SK; Gazzara MR; Carroll M; Taylor D; Lynch KW; Barash Y; Thomas-Tikhonenko A
    Nucleic Acids Res; 2018 Nov; 46(21):11357-11369. PubMed ID: 30357359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
    Basheer F; Giotopoulos G; Meduri E; Yun H; Mazan M; Sasca D; Gallipoli P; Marando L; Gozdecka M; Asby R; Sheppard O; Dudek M; Bullinger L; Döhner H; Dillon R; Freeman S; Ottmann O; Burnett A; Russell N; Papaemmanuil E; Hills R; Campbell P; Vassiliou GS; Huntly BJP
    J Exp Med; 2019 Apr; 216(4):966-981. PubMed ID: 30890554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
    Ghram M; Morris G; Culjkovic-Kraljacic B; Mars JC; Gendron P; Skrabanek L; Revuelta MV; Cerchietti L; Guzman ML; Borden KLB
    EMBO J; 2023 Apr; 42(7):e110496. PubMed ID: 36843541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
    Rio-Machin A; Vulliamy T; Hug N; Walne A; Tawana K; Cardoso S; Ellison A; Pontikos N; Wang J; Tummala H; Al Seraihi AFH; Alnajar J; Bewicke-Copley F; Armes H; Barnett M; Bloor A; Bödör C; Bowen D; Fenaux P; Green A; Hallahan A; Hjorth-Hansen H; Hossain U; Killick S; Lawson S; Layton M; Male AM; Marsh J; Mehta P; Mous R; Nomdedéu JF; Owen C; Pavlu J; Payne EM; Protheroe RE; Preudhomme C; Pujol-Moix N; Renneville A; Russell N; Saggar A; Sciuccati G; Taussig D; Toze CL; Uyttebroeck A; Vandenberghe P; Schlegelberger B; Ripperger T; Steinemann D; Wu J; Mason J; Page P; Akiki S; Reay K; Cavenagh JD; Plagnol V; Caceres JF; Fitzgibbon J; Dokal I
    Nat Commun; 2020 Feb; 11(1):1044. PubMed ID: 32098966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
    Jin P; Tan Y; Zhang W; Li J; Wang K
    Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of EZH2 in Acute Myeloid Leukemia.
    Jiao W; Liu Y; Bao Y
    Comput Intell Neurosci; 2022; 2022():8741989. PubMed ID: 36052036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia.
    Yang X; Wan M; Yu F; Wu X
    Cell Signal; 2021 Nov; 87():110144. PubMed ID: 34509612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
    Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
    Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
    Dolnik A; Engelmann JC; Scharfenberger-Schmeer M; Mauch J; Kelkenberg-Schade S; Haldemann B; Fries T; Krönke J; Kühn MW; Paschka P; Kayser S; Wolf S; Gaidzik VI; Schlenk RF; Rücker FG; Döhner H; Lottaz C; Döhner K; Bullinger L
    Blood; 2012 Nov; 120(18):e83-92. PubMed ID: 22976956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 mutation in an adolescent with Weaver syndrome developing acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis.
    Usemann J; Ernst T; Schäfer V; Lehmberg K; Seeger K
    Am J Med Genet A; 2016 May; 170A(5):1274-7. PubMed ID: 26762561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
    Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
    Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
    Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
    Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.
    Göllner S; Oellerich T; Agrawal-Singh S; Schenk T; Klein HU; Rohde C; Pabst C; Sauer T; Lerdrup M; Tavor S; Stölzel F; Herold S; Ehninger G; Köhler G; Pan KT; Urlaub H; Serve H; Dugas M; Spiekermann K; Vick B; Jeremias I; Berdel WE; Hansen K; Zelent A; Wickenhauser C; Müller LP; Thiede C; Müller-Tidow C
    Nat Med; 2017 Jan; 23(1):69-78. PubMed ID: 27941792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.